Matches in Wikidata for { <http://www.wikidata.org/entity/Q96617475> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q96617475 description "article scientifique publié en 2020" @default.
- Q96617475 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96617475 description "scientific article published on 20 June 2020" @default.
- Q96617475 description "wetenschappelijk artikel" @default.
- Q96617475 description "наукова стаття, опублікована 20 червня 2020" @default.
- Q96617475 name "Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran" @default.
- Q96617475 name "Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran" @default.
- Q96617475 type Item @default.
- Q96617475 label "Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran" @default.
- Q96617475 label "Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran" @default.
- Q96617475 prefLabel "Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran" @default.
- Q96617475 prefLabel "Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran" @default.
- Q96617475 P1433 Q96617475-EF3DF1C1-02FB-4E2F-8301-C19A983EB3E2 @default.
- Q96617475 P1476 Q96617475-DBF857EA-BA87-4741-A4AB-D031A46C7972 @default.
- Q96617475 P2093 Q96617475-05897159-BC58-442E-80F4-C8D99AFC4F8E @default.
- Q96617475 P2093 Q96617475-1D2EED93-4379-4ABB-808A-10D49EB16410 @default.
- Q96617475 P2093 Q96617475-42ABD457-786D-4B62-BB78-544017EABAE1 @default.
- Q96617475 P2093 Q96617475-5187EABE-3776-437B-80CA-43B490642F6E @default.
- Q96617475 P2093 Q96617475-9E0738EA-3837-4BFD-8A2A-327C438FEF1D @default.
- Q96617475 P2093 Q96617475-B7CA54CB-A6CB-432C-AC9C-38EFFCF73786 @default.
- Q96617475 P2093 Q96617475-C3D450D1-F89E-4D5F-83B8-232CBD90DD2D @default.
- Q96617475 P2093 Q96617475-CA73A33D-14A7-4EFB-A60E-E8F64800444D @default.
- Q96617475 P2093 Q96617475-EB1C3157-6513-469D-BFDC-7CF002821A84 @default.
- Q96617475 P31 Q96617475-27092C2A-F251-4F89-8C15-80244993F52F @default.
- Q96617475 P356 Q96617475-968DF919-880E-4227-AECF-1B8C9EC419BC @default.
- Q96617475 P50 Q96617475-5C212311-4417-4C24-8082-DBC1A85F3BD2 @default.
- Q96617475 P577 Q96617475-DDFF8B28-0A17-4D8E-AF7D-55FFA02EFC45 @default.
- Q96617475 P698 Q96617475-0F3266AB-5D23-42AD-BE5F-27F73742619F @default.
- Q96617475 P921 Q96617475-947172D5-06E6-4EE6-B960-1A69E2585DBF @default.
- Q96617475 P921 Q96617475-BE598791-3437-4BBA-AFDE-C35E24BA7AA6 @default.
- Q96617475 P356 S12325-020-01414-X @default.
- Q96617475 P698 32564268 @default.
- Q96617475 P1433 Q4686392 @default.
- Q96617475 P1476 "Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran" @default.
- Q96617475 P2093 "Dolores Ochoa" @default.
- Q96617475 P2093 "Dora Koller" @default.
- Q96617475 P2093 "Gina Mejía" @default.
- Q96617475 P2093 "Manuel Román" @default.
- Q96617475 P2093 "Marcos Navares-Gómez" @default.
- Q96617475 P2093 "Miriam Saiz-Rodríguez" @default.
- Q96617475 P2093 "Pablo Zubiaur" @default.
- Q96617475 P2093 "Paula Soria-Chacartegui" @default.
- Q96617475 P2093 "Susana Almenara" @default.
- Q96617475 P31 Q13442814 @default.
- Q96617475 P356 "10.1007/S12325-020-01414-X" @default.
- Q96617475 P50 Q42394212 @default.
- Q96617475 P577 "2020-06-20T00:00:00Z" @default.
- Q96617475 P698 "32564268" @default.
- Q96617475 P921 Q323936 @default.
- Q96617475 P921 Q419345 @default.